Cite
HARVARD Citation
Morgenstern, Y. et al. (2021). Dose‐adjusted EPOCH‐R is not superior to sequential R‐CHOP/R‐ICE as a frontline treatment for newly diagnosed primary mediastinal B‐cell lymphoma: Results of a bi‐center retrospective study. Cancer medicine. pp. 8866-8875. [Online].